PCORI research award to explore integration of patient strengths in treatment

NewsGuard 100/100 Score

Project part of PCORI's effort to help patients make better-informed health decisions

Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.

Kurt C. Stange, MD, PhD, Professor of Family Medicine & Community Health at the School of Medicine will lead the research project, which departs from the typical care model focusing on patient challenges or weaknesses. Instead, researchers will explore how patient strengths can be integrated into assessment and treatment to improve patient outcomes. Strengths could include a patient's resilience or mindfulness, as well as relationships with family and friends and resources available within the community.

Case Western Reserve researchers will work with patients and clinicians in the Safety Net Providers' Strategic Alliance-a Cleveland-area consortium (known formally as a Practice-Based Research Network) involving 17 community health centers and two free clinics. The project team also includes collaborators at the University of Oslo in Norway and the University of North Carolina at Chapel Hill who will help develop an interactive online tool to assess patient strengths. The researchers will create computerized simulation models to compare outcomes from employing patient-identified strengths to deficit and symptom-focused care.

"Today marks a major milestone in our work as we build a portfolio of comparative clinical effectiveness research that will provide patients and those who care for them better information about the health care decisions they face," said PCORI Executive Director Joe Selby, MD, MPH. "These research projects reflect PCORI's patient-centered research agenda, emphasizing the inclusion of patients and caregivers at all stages of the research."

PCORI is committing $40.7 million in funding for a slate of 25 projects, which were approved by PCORI's Board of Governors following a competitive, multi-stage review process involving scientists, patients, caregivers and other stakeholders. Proposals were evaluated on the basis of scientific merit, engagement of patients and stakeholders, methodological rigor and fit within PCORI's National Priorities for Research and Research Agenda.

The awards were part of PCORI's first cycle of primary research funding and selected from among nearly 500 completed applications submitted earlier this year. All proposals were approved pending a business and programmatic review by PCORI staff and completion of a formal award contract. The amount of the award will be finalized after that process.

"This award will allow us to work with community and university partners to develop and evaluate an approach that brings patients' often untapped personal, family and community strengths into the process of health care, healing and health promotion," Stange said. "Instead of the usual approach of focusing primarily on deficits, this model has the potential to give patients and their partners a more fully informed and empowered role in advancing their well-being."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microfluidic chips advance neurodegenerative disease research